Page 141 - Williams Hematology ( PDFDrive )
P. 141

116            Part III:  Epochal Hematology                                                                                                                          Chapter 7:  Hematology of the Fetus and Newborn              117




                 235. Shulman NR, Jordan JV Jr: Platelet immunology, in Hemostasis and Thrombosis: Basic     272. Blaese RM, Poplack DG, Muchmore AV: The mononuclear phagocyte system: Role in
                  Principles and Clinical Practice, 2nd ed, edited by RW Colman, J Hirsh, VJ Marder, EW   expression of immunocompetence in neonatal and adult life. Pediatrics 64:829, 1977.
                  Salzman, pp 476–483. JB Lippincott, Philadelphia, 1987.    273. Holroyde CP, Oski FA, Gardner FH: The “pocked” erythrocyte. N Engl J Med 281:516,
                 236. Pabst HF: Ontogeny of the immune response as a basis of childhood diseases. J Pediatr   1969.
                  97:519, 1980.                                         274. Freedman RM, Johnston D, Mahoney MJ, et al: Development of splenic reticuloendo-
                 237. O’Gorman MRG, Millard DD, Lowder JN, et al: Lymphocyte subpopulations in 1–3 day   thelial function in neonates. J Pediatr 96:466, 1980.
                  old infants. Cytometry 34:235 1998.                   275. Gross SJ, Stuart MJ: Hemostasis in the premature infant. Clin Perinatol 4:259, 1977.
                 238. Shearer WT, Rosenblatt HM, Gelman RS, et al: Lymphocyte subsets in healthy children     276. Barnard DR, Hathaway WE: Neonatal thrombosis. Am J Pediatr Hematol Oncol 1:235,
                  from birth through 18 years of age: The Pediatric AIDS Clinical Trials Group P1009   1979.
                  Study. J Allergy Clin Immunol 112:973, 2003.          277. Bleyer WA, Hakami N, Shepard TH: The development of hemostasis in the human fetus
                 239. De Waele M, Foulon W, Renmans W, et al: Hematologic values and lymphocyte subsets   and newborn infant. J Pediatr 79:838, 1971.
                  in fetal blood. Am J Clin Pathol 89:742, 1988.        278. Andrew M, Paes B, Milner B, et al: Development of the human coagulation system in
                 240. Hicks MJ, Jones JF, Minnich LL, et al: Age-related changes in T- and B-lymphocyte   the full-term infant. Blood 70:165, 1987.
                  subpopulations in the peripheral blood. Arch Pathol Lab Med 107:518, 1983.    279. Andrew M, Paes B, Milner R, et al: Development of the human coagulation system in
                 241. Kotylo PA, Baenzinger JC, Yoder MC, et al: Rapid analysis of lymphocyte subsets in   the healthy premature infant. Blood 72:1651, 1988.
                  cord blood. Am J Clin Pathol 93:263, 1990.            280. Corrigan JJ Jr: Neonatal thrombosis and the thrombolytic system: Pathophysiology and
                 242. Kohl S: Human neonatal natural killer cell cytotoxicity function. Pediatr Infect Dis J   therapy. Am J Pediatr Hematol Oncol 10:83, 1988.
                  18:635, 1999.                                         281. Monagle P, Massicotte P: Developmental haemostasis: Secondary haemostasis. Semin
                 243. Adkins B. Neonatal T cell function. J Pediatr Gastroenterol Nutr 40:S5, 2005.  Fetal Neonatal Med 16:294, 2011.
                 244. Comans-Bitter WM, de Groot R, van den Beemd R, et al: Immunophenotyping of     282. Andrew M, Paes B, Johnston M: Development of the hemostatic system in the neonate
                  blood lymphocytes in childhood. Reference values for lymphocyte subpopulations. J   and young infant. Am J Pediatr Hematol Oncol 12:95, 1990.
                  Pediatr 130:388, 1997.                                283. Andrew M: The relevance of developmental hemostasis to hemorrhagic disorders of
                 245. Slukvin II, Chernishov VP: Two-color flow cytometric analysis of natural killer and   newborns. Semin Perinatol 21:70, 1997.
                  cytotoxic T-lymphocyte subsets in peripheral blood of normal human neonates. Biol     284. Karpatkin M, Lee M, Cohen L, et al: Synthesis of coagulation proteins in the fetus and
                  Neonate 61:156, 1992.                                  neonate. J Pediatr Hematol Oncol 22:276, 2000.
                 246. Neubert R, Delgado I, Abraham K, et al: Evaluation of the age-dependent development     285. Furie B, Furie BC: Molecular basis of gamma-carboxylation. Role of the propeptide in
                  of lymphocyte surface receptors in children. Life Sci 62:1099, 1998.  the vitamin K-dependent proteins. Ann N Y Acad Sci 614:1, 1991.
                 247. Miller ME: Immune-inflammatory response in the human neonate.  Am J Pediatr     286. Aballi AJ, deLamerens S: Coagulation changes in the neonatal period and in early
                  Hematol Oncol 3:199, 1981.                             infancy. Pediatr Clin North Am 9:785, 1962.
                 248. Stiehm ER, Winter HS, Bryson YF: Cellular (T cell) immunity in the human new-born.     287. Muntean W, Petek W, Rosanelli K, et al: Immunologic studies of prothrombin in new-
                  Pediatrics 64:814, 1979.                               borns. Pediatr Res 13:1262, 1979.
                 249. Carr MC, Stites DP, Fudenberg HH: Cellular immune aspects of the human fetal-     288. Lane PA, Hathaway WE: Vitamin K in infancy. J Pediatr 106:351, 1985.
                  maternal relationship. I. In vitro response of cord blood lymphocytes to phytohemag-    289. Stevenson RE, Burton OM, Ferlauto GJ, et al: Hazards of oral anticoagulants during
                  glutinin. Cell Immunol 5:21, 1972.                     pregnancy. JAMA 243:1549, 1980.
                 250. Papiernick M: Comparison of human foetal with child blood lymphocytic kinetics. Biol     290. Shearer MJ: Annotation: Vitamin K and vitamin K-dependent proteins. Br J Haematol
                  Neonate 19:163, 1971.                                  75:156, 1990.
                 251. Uhr JW, Dancis J, Newmann CG: Delayed-type hypersensitivity in premature neonatal     291. von Kries R, Hanawa Y: Neonatal vitamin K prophylaxis. Report of Scientific and Stan-
                  humans. Nature 187:1130, 1960.                         dardization Subcommittee on Perinatal Haemostasis. Thromb Haemost 69:293, 1993.
                 252. Blaese RM, Poplack DG, Muchmore AV: The mononuclear phagocyte system: Role in     292. Sutor AH, Gobel U, Kries RV, et al: Vitamin K prophylaxis in the newborn. Blut 60:275,
                  expression of immunocompetence in neonatal and adult life. Pediatrics 64(Suppl):829,   1990.
                  1979.                                                 293. Hathaway WE, Isarangkura PB, Mahasandana C, et al: Comparison of oral and parent-
                 253. Von Freeden U, Zessack N, Van Valen F, Burdach S: Defective interferon gamma pro-  eral vitamin K prophylaxis for prevention of late hemorrhagic disease of the newborn.
                  duction in neonatal T cells is independent of interleukin-2 receptor binding. Pediatr Res   J Pediatr 119:461, 1991.
                  30:270, 1991.                                         294. Blackmon L, Batton DG, Bell EF, et al: Controversies concerning vitamin K and the
                 254. Sterm CMM: Changes in lymphocytes subpopulations in the blood of healthy and sick   newborn. American Academy of Pediatrics Policy Statement. Pediatrics 112:191, 2003.
                  newborn infants. Pediatr Res 13:792, 1979.            295. Costakos DT, Porte M: Did “controversies concerning vitamin K and the newborn”
                 255. Raveche ES: Possible immunoregulatory role for CD5+ B cells. Clin Immunol Immuno-  cover all the controversies? Pediatrics 113:1466, 2004.
                  pathol 56:135, 1990.                                  296. Clarke P, Mitchell SJ, Wynn R, et al: Vitamin K prophylaxis for preterm infants: A ran-
                 256. Wilson CB, Kollmann TR: Induction of antigen specific immunity in human neonates   domized, controlled trial of three regimens. Pediatrics 118:1657, 2006.
                  and infants [review]. Nestle Nutr Workshop Ser Pediatr Program 61:183 2008.    297. Amadee-Manesme O, Labert WE, Alagille D, De Leenheer AP: Pharmacokinetics and
                 257. Gustafsson BE, Laurell CB: Gamma globulin production in germ free rats after bacterial   safety of a new solution of vitamin K1(20) in children with cholestasis. J Pediatr Gas-
                  contamination. J Exp Med 110:675, 1959.                troenterol Nutr 14:160, 1996.
                 258. Gitlin D: The differentiation and maturation of specific immune mechanisms. Acta Pae-    298. Aballi AJ: The action of vitamin K in the neonatal period. South Med J 58:48, 1965.
                  diatr Scand 172(Suppl):60, 1967.                      299. Gray OP, Ackerman A, Fraser AJ: Intracranial haemorrhage and clotting in low-birth-
                 259. Stiehm ER: Fetal defense mechanisms. Am J Dis Child 129:438, 1975.  weight infants. Lancet 1:545, 1968.
                 260. Goldman AS, Garza C, Nichols BL, Goldblum RM: Immunological factors in human     300. Volpe JJ: Neonatal intraventricular hemorrhage. N Engl J Med 304:886, 1981.
                  milk during the first year of lactation. J Pediatr 100:563, 1982.    301. Appleyard WJ, Cottom DG: Effect of asphyxia on Thrombotest values in low birthwei-
                 261. Goldman AS, Ham Pong AJ, Goldblum RM: Host defenses: Development and maternal   ght infants. Arch Dis Child 45:705, 1970.
                  contributions. Adv Pediatr 32:71, 1985.               302. Schmidt B, Zipursky A: Thrombotic disease in newborn infants. Clin Perinatol 2:461,
                 262. Newburg DS, Walker WA: Protection of the neonate by the innate immune system of   1984.
                  developing gut and of human milk. Pediatr Res 61:2 2007.    303. Rodgers GM, Shuman MA: Congenital thrombotic disorders. Am J Hematol 21:419,
                 263. Rothberg RM: Immunoglobulin and specific antibody synthesis during the first weeks   1986.
                  of life of premature infants. J Pediatr 75:391, 1969.    304. Sifontes MT, Nuss R, Hunger SP, et al: Correlation between the functional assay for
                 264. Harworth JC, Norris M, Dilling L: A study of the immunoglobulins in premature   activated protein C resistance and factor V Leiden in the neonate. Pediatr Res 42:776,
                  infants. Arch Dis Child 40:243, 1965.                  1997.
                 265. Thom H, McKay E, Gray DWG: Protein concentrations in the umbilical cord plasma of     305. Leroyer C, Mercier B, Oger E, et al: Prevalence of 20210 A allele of the prothrombin
                  premature and mature infants. Clin Sci 33:433, 1967.   gene in venous thromboembolism patients. Thromb Haemost 80:49, 1998.
                 266. Yeung CY, Hoffs JR: Serum gamma-G-globulin levels in normal, premature, postma-    306. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in
                  ture, and “small-for-dates” newborn babies. Lancet 1:1167, 1968.  the 3′-untranslated region of the prothrombin gene is associated with elevated plasma
                 267. Sever JH: Immunological responses to perinatal responses to perinatal infections. J   prothrombin levels and an increase in venous thrombosis. Blood 88:3698, 1996.
                  Pediatr 75:1111, 1969.                                307. Miller RK, Kellogg CR, Saltzman RA: Reproductive and perinatal toxicology, in Hand-
                 268. Thomaidis T, Agathopoulos A, Matsaniotis N: Natural isohemagglutinin production by   book of Toxicology, edited by TJ Haley, WO Berndt, pp 195–309. Hemisphere Publish-
                  the fetus. J Pediatr 74:39, 1969.                      ing, Washington, DC, 1987.
                 269. Morito T, Bankhurst AD, Williams RC Jr: Studies of human cord blood and adult lym-    308. Gray MJ: Use and abuse of thiazides in pregnancy. Clin Obstet Gynecol 11:568, 1968.
                  phocyte interactions with in vitro immunoglobulin production. J Clin Invest 64:990,     309. Leikin SL: Thiazide and neonatal thrombocytopenia. N Engl J Med 271:161, 1964.
                  1979.                                                 300. Ginsberg JS, Kowalchuk G, Hirsh J, Brill-Edwards P, Burrows R: Heparin therapy dur-
                 270. Miyagawa Y, Sugita K, Komiyama A, et al: Delayed in vitro immunoglobulin produc-  ing pregnancy. Arch Intern Med 149:2233, 1989.
                  tion by cord lymphocytes. Pediatrics 65:497, 1980.    311. Page TE, Hoyme HE, Markarian M, et al: Neonatal hemorrhage secondary to thrombo-
                 271. Ferguson  AC,  Cheung  SC: Modulation  of immunoglobulin  M  and  G synthesis  by   cytopenia: An occasional effect of prenatal hydantoin exposure. Birth Defects Orig Artic
                  monocytes and T lymphocytes in the newborn infant. J Pediatr 98:385, 1981.  Ser 18:47, 1982.







          Kaushansky_chapter 07_p0097-0118.indd   116                                                                   9/18/15   10:13 PM
   136   137   138   139   140   141   142   143   144   145   146